Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CorMedix (CRMD) Accounts Payables: 2012-2025

Historic Accounts Payables for CorMedix (CRMD) over the last 11 years, with Sep 2025 value amounting to $20.5 million.

  • CorMedix's Accounts Payables rose 1422.09% to $20.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $20.5 million, marking a year-over-year increase of 1422.09%. This contributed to the annual value of $1.7 million for FY2024, which is N/A change from last year.
  • According to the latest figures from Q3 2025, CorMedix's Accounts Payables is $20.5 million, which was up 251.73% from $5.8 million recorded in Q2 2025.
  • Over the past 5 years, CorMedix's Accounts Payables peaked at $20.5 million during Q3 2025, and registered a low of $943,344 during Q2 2021.
  • For the 3-year period, CorMedix's Accounts Payables averaged around $4.4 million, with its median value being $2.6 million (2023).
  • In the last 5 years, CorMedix's Accounts Payables tumbled by 60.69% in 2021 and then spiked by 1,422.09% in 2025.
  • CorMedix's Accounts Payables (Quarterly) stood at $2.2 million in 2021, then decreased by 0.34% to $2.2 million in 2022, then skyrocketed by 35.01% to $2.4 million in 2023, then plummeted by 43.68% to $1.7 million in 2024, then surged by 1,422.09% to $20.5 million in 2025.
  • Its Accounts Payables stands at $20.5 million for Q3 2025, versus $5.8 million for Q2 2025 and $1.9 million for Q1 2025.